# 1. Description:
----------------------------------------------------------------------------------------------------------------------------

This repository hosts resources and analyses related to the investigation of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). The focus is primarily on metabolite observations to understand disease progression. The project encompasses a thorough examination of lipid metabolism, mechanistic computational modeling, and exploration of therapeutic interventions.

![image](https://github.com/Meet2197/Metabolites-Visualisation/assets/125220294/de02ecc0-0049-435b-95c6-e35026025661)


# 2. Contents:
----------------------------------------------------------------------------------------------------------------------------

Data Analysis: This section contains scripts and notebooks for preprocessing data, conducting exploratory data analysis, and visualizing metabolite observations relevant to MASLD progression.

Mechanistic Models: Here, you'll find code and documentation for developing mechanistic computational models aimed at elucidating MASLD-specific alterations in lipid metabolism. These models particularly focus on VLDL production and secretion mechanisms.

Therapeutic Interventions: This section provides insights into the use of medications like metformin, ramipril, and pioglitazone for treating MASLD. It includes analyses of their effects on lipid metabolism and disease progression.


![diagram Lipid Metabolism](https://github.com/Meet2197/Metabolites-Visualisation/assets/125220294/55a57765-c536-4852-96fb-a76e04d3d7ec)

# 3. Dependencies:
----------------------------------------------------------------------------------------------------------------------------
R version 4.1.2
Required libraries (e.g., R Shiny, nlopt, Bioconductor, etc.)

# 4. Data Sources:
----------------------------------------------------------------------------------------------------------------------------

Data for this project were obtained from the UK Biobank in 2023. The dataset encompasses metabolite observations and relevant clinical information associated with MASLD.

# 5. Instructions:
----------------------------------------------------------------------------------------------------------------------------

Clone the repository to your local machine.
Navigate to specific directories for data analysis, mechanistic models, and therapeutic interventions.
Follow the provided README and documentation for executing scripts, running analyses, and interpreting results.
Ensure all necessary dependencies are installed in your R environment.
Contact project maintainers listed in the README for inquiries or assistance.

# 6. Acknowledgments:
----------------------------------------------------------------------------------------------------------------------------

This project is supported by funding from DFZ and Uniklinik Aachen. Special thanks to the UK Biobank for providing the crucial dataset essential for advancing our understanding of MASLD.

![image](https://github.com/Meet2197/Metabolites-Visualisation/assets/125220294/4f34da6e-32ad-4356-8f3d-3016dc9fcdf5)  ![image](https://github.com/Meet2197/Metabolites-Visualisation/assets/125220294/50f14128-a55f-4e4a-83af-75b7ebe9a583)

# 7. License:
----------------------------------------------------------------------------------------------------------------------------

Please specify the license under which the project and its contents are distributed (e.g., MIT License).

# 8. Contact Information:
----------------------------------------------------------------------------------------------------------------------------

For inquiries, collaborations, or further information, reach out to the project lead or maintainers through provided contact details.

# 9. Future Directions:
----------------------------------------------------------------------------------------------------------------------------

Highlight potential future directions for the project, including planned analyses, model enhancements, or additional therapeutic investigations.